Real-World Treatment of ADC-Resistant HER2-Low Advanced Breast Cancer
Clinical trial NCT07587983 · COMPLETED
Trial details
- NCT number
- NCT07587983
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-01
- Primary completion
- 2025-12-31
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.